Genting Plantations Berhad logo

Genting Plantations Berhad (2291)

Market Closed
11 Aug, 07:45
XKLS XKLS
RM
5. 60
-0.04
-0.7092%
RM
- Market Cap
- P/E Ratio
2.5% Div Yield
71,500 Volume
- Eps
RM 5.64
Previous Close
Add Transaction
Day Range
5.53 5.67
Year Range
4.76 5.77
Want to track 2291 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2291 closed today lower at RM5.6, a decrease of -0.7092% from yesterday's close, completing a monthly increase of 7.0746% or RM0.37. Over the past 12 months, 2291 stock gained 10.0196%.
2291 pays dividends to its shareholders, with the most recent payment made on Mar 30, 2026. The next estimated payment will be in 4 months ago on Mar 30, 2026 for a total of RM0.18.
The last earnings report, released on May 27, 2026, missed the consensus estimates by -0.085%. On average, the company has fell short of earnings expectations by -0.0275%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2291 Chart

Genting Plantations Berhad (2291) FAQ

What is the stock price today?

The current price is RM5.60.

On which exchange is it traded?

Genting Plantations Berhad is listed on XKLS.

What is its stock symbol?

The ticker symbol is 2291.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.5%.

What is its market cap?

As of today, no market cap data is available.

Has Genting Plantations Berhad ever had a stock split?

No, there has never been a stock split.

Genting Plantations Berhad Profile

Health Care Technology Industry
Healthcare Sector
- CEO
XKLS Exchange
MYL2291OO002 ISIN
China Country
239 Employees
27 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., established in 1994 and headquartered in Shanghai, China, operates as an investment holding company with a global reach in the medical technology sector. The company is deeply engaged in the research, development, manufacture, and commercialization of interventional medical devices, offering advanced solutions for the treatment of various cardiovascular and congenital heart conditions. As a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd., LEPU ScienTech has carved a niche for itself by specializing in an array of interventional medical devices that cater to the needs of hospitals and distributors worldwide.

Products and Services

  • Congenital Heart Diseases Interventional Treatment Solutions

    LEPU ScienTech provides a comprehensive range of products designed for the treatment of congenital heart diseases. This includes occluder products for atrial septal defects, ventricular septal defects, and patent ductus arteriosus. Additionally, the company offers specialized delivery systems and snare products to support the deployment of these treatments.

  • Cardioembolic Stroke Prevention Solutions

    The company’s portfolio includes left atrial appendage and patent foramen ovale occluder products, aimed at preventing strokes that may be caused by blood clots originating from the heart. These products are crucial for patients at risk of cardioembolic strokes, providing an effective preventive measure.

  • Treatment of Valvular Disease Solutions

    Offering a range of products for the treatment of valvular diseases, LEPU ScienTech has developed solutions for aortic, mitral, tricuspid, and pulmonary valve conditions. These include various valve products and procedural accessories essential for the successful treatment of valve-related heart diseases.

  • Vascular Plugs and Interatrial Shunt Devices

    The company also manufactures vascular plugs and interatrial shunt devices, which are used to control abnormal blood flow within the heart or between blood vessels. These innovative devices are crucial for patients needing precise management of their blood flow to prevent or treat various cardiovascular conditions.

Contact Information

Address: Building 41
Phone: 86 21 3701 5600